Braintree Says Suprep Case Doesn't Upend Drug Patent Law

Braintree Says Suprep Case Doesn't Upend Drug Patent Law

Braintree Laboratories Inc. has urged the full Federal Circuit to reject Novel Laboratories Inc.'s argument that a panel decision in the companies' patent dispute over the colon cleanser Suprep flouted drug patent law by holding that an unapproved ...read more

  • Tags: